PH27432A - Homogeneous recombinant immune interferon fragments and pharmaceuticals compositions containing same - Google Patents

Homogeneous recombinant immune interferon fragments and pharmaceuticals compositions containing same

Info

Publication number
PH27432A
PH27432A PH35656A PH35656A PH27432A PH 27432 A PH27432 A PH 27432A PH 35656 A PH35656 A PH 35656A PH 35656 A PH35656 A PH 35656A PH 27432 A PH27432 A PH 27432A
Authority
PH
Philippines
Prior art keywords
compositions containing
containing same
immune interferon
homogeneous recombinant
recombinant immune
Prior art date
Application number
PH35656A
Other languages
English (en)
Inventor
Heinz Dr Dobeli
Erich Dr Hochuli
Reiner Dr Gentz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH27432A publication Critical patent/PH27432A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/57IFN-gamma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Pain & Pain Management (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PH35656A 1986-08-13 1987-08-12 Homogeneous recombinant immune interferon fragments and pharmaceuticals compositions containing same PH27432A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868619725A GB8619725D0 (en) 1986-08-13 1986-08-13 Homogenous interferon fragments

Publications (1)

Publication Number Publication Date
PH27432A true PH27432A (en) 1993-06-21

Family

ID=10602667

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35656A PH27432A (en) 1986-08-13 1987-08-12 Homogeneous recombinant immune interferon fragments and pharmaceuticals compositions containing same

Country Status (21)

Country Link
EP (1) EP0256424B1 (de)
JP (1) JPS6349098A (de)
KR (1) KR880002996A (de)
AR (1) AR244808A1 (de)
AT (1) ATE67783T1 (de)
AU (1) AU607930B2 (de)
DE (1) DE3773295D1 (de)
DK (1) DK377787A (de)
ES (1) ES2051714T3 (de)
FI (1) FI873512A (de)
GB (1) GB8619725D0 (de)
GR (1) GR3003417T3 (de)
HU (1) HU202920B (de)
IE (1) IE60670B1 (de)
IL (1) IL83474A0 (de)
MC (1) MC1847A1 (de)
NO (1) NO174631C (de)
NZ (1) NZ221374A (de)
PH (1) PH27432A (de)
PT (1) PT85538B (de)
ZA (1) ZA875819B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2969461B2 (ja) * 1988-07-23 1999-11-02 株式会社林原生物化学研究所 ヒトγ−インターフェロンとその製造方法並びに用途
DE3730331A1 (de) * 1987-09-10 1989-03-30 Basf Ag Neue polypeptide, verfahren zur herstellung, die vektoren dafuer und arzneimittel daraus
WO1992004377A1 (en) * 1990-08-31 1992-03-19 Schering Corporation HUMAN INTERFERON-η4-134, FUNCTIONAL EQUIVALENTS THEREOF AND METHODS OF USING AND COMPOSITIONS EMPLOYING THESE MATERIALS
DE4036856C1 (de) * 1990-11-19 1992-05-27 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung Ev, 8000 Muenchen, De
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
SK8292002A3 (en) 1999-11-12 2002-12-03 Maxygen Holdings Ltd A conjugate exhibiting interferon gamma activity, nucleotide sequence encoding for a polypeptide fraction of conjugate, an expression vector and a host cell containing nucleotide sequence, pharmaceutical composition comprising the same and use thereof
CN1309423C (zh) 1999-11-12 2007-04-11 马克西根控股公司 干扰素γ偶联物
US7959910B2 (en) 2000-07-31 2011-06-14 Biolex Therapeutics, Inc. C-terminally truncated interferon alpha variants
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
US7038015B2 (en) 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
EP1539814A2 (de) 2002-07-03 2005-06-15 Maxygen Holdings Ltd. c/o Close Brothers (Cayman) Limited Ungekürzte interferon-gamma-polypeptidvarianten
US20060024272A1 (en) * 2004-07-29 2006-02-02 Large Scale Biology Corporation C-terminally truncated interferon

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0788398B2 (ja) * 1983-10-17 1995-09-27 サントリー株式会社 新規生理活性ポリペプチドおよびその製造法
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
JPS60172999A (ja) * 1983-12-20 1985-09-06 Suntory Ltd 新規な塩基性ポリペプチドおよびその製造法
DK168016B1 (da) * 1983-12-26 1994-01-17 Kyowa Hakko Kogyo Kk Derivat af humant interferon-gamma-polypeptid
DE3414831A1 (de) * 1984-04-19 1985-10-31 Hoechst Ag, 6230 Frankfurt Herstellung von polypeptiden mit human-gammainterferon-aktivitaet
WO1985005618A1 (en) * 1984-06-06 1985-12-19 Takeda Chemical Industries, Ltd. Process for preparing interferon derivative
IL75302A0 (en) * 1984-06-06 1985-09-29 Takeda Chemical Industries Ltd Novel polypeptide and production thereof
JPS6124599A (ja) * 1984-07-11 1986-02-03 Kyowa Hakko Kogyo Co Ltd 新規ヒトインタ−フエロン−rポリペプチド誘導体
JPS6163696A (ja) * 1984-09-05 1986-04-01 Asahi Chem Ind Co Ltd 新しいペプチド
JPS61108397A (ja) * 1984-10-31 1986-05-27 Green Cross Corp:The インタ−フエロン−γ蛋白質の製造法
JPS62289600A (ja) * 1986-02-18 1987-12-16 Kanegafuchi Chem Ind Co Ltd インタ−フエロン−γ及びその製造方法

Also Published As

Publication number Publication date
NO873389D0 (no) 1987-08-12
ZA875819B (en) 1988-02-15
ES2051714T3 (es) 1994-07-01
GB8619725D0 (en) 1986-09-24
IL83474A0 (en) 1988-01-31
NO873389L (no) 1988-02-15
KR880002996A (ko) 1988-05-13
JPS6349098A (ja) 1988-03-01
DE3773295D1 (de) 1991-10-31
NO174631C (no) 1994-06-08
IE60670B1 (en) 1994-08-10
AR244808A1 (es) 1993-11-30
DK377787D0 (da) 1987-07-20
AU607930B2 (en) 1991-03-21
MC1847A1 (fr) 1988-09-30
NO174631B (no) 1994-02-28
GR3003417T3 (en) 1993-02-17
FI873512A0 (fi) 1987-08-13
AU7668687A (en) 1988-05-19
HU202920B (en) 1991-04-29
EP0256424A1 (de) 1988-02-24
FI873512A (fi) 1988-02-14
EP0256424B1 (de) 1991-09-25
PT85538B (pt) 1990-06-29
HUT47148A (en) 1989-01-30
NZ221374A (en) 1990-07-26
DK377787A (da) 1988-02-14
PT85538A (en) 1987-09-01
ATE67783T1 (de) 1991-10-15
IE872160L (en) 1988-02-13

Similar Documents

Publication Publication Date Title
IL82221A0 (en) Phenyl-piperazines and pharmaceutical compositions containing them
NZ222980A (en) 3-aryloxy-3-substituted propanamines and pharmaceutical compositions
NZ220365A (en) Antiviral peptides and pharmaceutical compositions
IL72799A0 (en) Peptides and pharmaceutical compositions containing them
NZ223096A (en) Peptidylaminodiols and pharmaceutical compositions
IL74384A (en) Crf antagonist peptides and pharmaceutical compositions containing them
NZ220020A (en) 1-hydroxy-2-pyridones and pharmaceutical composition
PT77573B (en) Human immune interferon protein and production thereof
GB2200132B (en) Stabilised enzyme systems and compositions containing them
IL71951A0 (en) Polypeptides having interferon activity,their preparation and pharmaceutical compositions containing them
IL85712A0 (en) Lyophilized lymphokine composition
PH27432A (en) Homogeneous recombinant immune interferon fragments and pharmaceuticals compositions containing same
IL82146A0 (en) Liposomes based on phosphatidyl-inositolmannosides and pharmaceutical compositions containing them
ZW4683A1 (en) Homogeneous human immune interferon and process therefor
ZA875633B (en) Recombinant htlv-iii proteins and uses thereof
NZ214702A (en) Using interferon in treatments and pharmaceutical compositions
NZ215563A (en) Interferon composition
NZ219027A (en) Antiviral composition containing interferon tumour necrosis factor and/or lymphotoxin
IL79858A0 (en) Peptide antibiotics,their preparation and compositions containing them
IL88934A0 (en) Recombinant human interleukin-1alpha polypeptides,their preparation and pharmaceutical compositions containing them
NZ219748A (en) Indenopyrimidines and pharmaceutical compositions
ZA866582B (en) Recombinant virus
NZ215936A (en) Rioprostil - pvp complex and pharmaceutical compositions
PT86162A (en) Recombinant protein expression
NZ222612A (en) Benzoquinolines and pharmaceutical compositions: intermediates